This report evaluates the clinical utility of cell-free DNA (cfDNA) (formerly noninvasive prenatal testing [NIPT] or noninvasive prenatal screening [NIPS]) screening for fetal rare autosomal aneuploidy (RAA) in women with singleton or twin pregnancies.
If you have a Hayes login, click here to view the full report on the Knowledge Center.